Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Gains from Sales and Divestitures: 2018-2025

Historic Gains from Sales and Divestitures for Mesa Laboratories (MLAB) over the last 8 years, with Sep 2025 value amounting to $62.

  • Mesa Laboratories' Gains from Sales and Divestitures rose 82.35% to $62 in Q3 2025 from the same period last year, while for Sep 2025 it was $62, marking a year-over-year increase of 82.35%. This contributed to the annual value of $37,000 for FY2025, which is 32.14% up from last year.
  • Per Mesa Laboratories' latest filing, its Gains from Sales and Divestitures stood at $62 for Q3 2025, which was up 16.98% from $53 recorded in Q2 2025.
  • Mesa Laboratories' Gains from Sales and Divestitures' 5-year high stood at $37,000 during Q1 2025, with a 5-year trough of $20 in Q2 2023.
  • Moreover, its 3-year median value for Gains from Sales and Divestitures was $36 (2024), whereas its average is $8,389.
  • Per our database at Business Quant, Mesa Laboratories' Gains from Sales and Divestitures surged by 46,328.57% in 2022 and then slumped by 99.85% in 2023.
  • Quarterly analysis of 5 years shows Mesa Laboratories' Gains from Sales and Divestitures stood at $28 in 2021, then soared by 46,328.57% to $13,000 in 2022, then slumped by 99.79% to $27 in 2023, then skyrocketed by 33.33% to $36 in 2024, then skyrocketed by 82.35% to $62 in 2025.
  • Its Gains from Sales and Divestitures stands at $62 for Q3 2025, versus $53 for Q2 2025 and $37,000 for Q1 2025.